Long-term inhaled treprostinil for PH-ILD: INCREASE open-label extension study.

The European respiratory journal(2023)

引用 3|浏览29
暂无评分
摘要
These results support the long-term safety and efficacy of inhaled treprostinil in patients with PH-ILD and are consistent with the results observed in the INCREASE RCT.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要